Clinical Trials Logo

Clinical Trial Summary

The purpose and objective of this study is to improve cholesterol treatment among blood donors with FH (Familial Hypercholesterolemia).


Clinical Trial Description

This is a single center randomized, two arm trial. The two study arms include usual care (standard notification) and implementation bundle intervention. UT Southwestern Medical Center will be the main study site and Carter Blood Care will serve as the recruitment site. Screening/Baseline visit: Donors agreeing to participate in the study will be informed of study procedures and will provide informed consent. A 20 mL blood sample as well as a urine sample will be obtained for eligibility screening laboratories and baseline LDL-C. Follow-up phone call: At 3 months post-randomization, participants in both arms will be briefly contacted by phone by the Research Assistant to thank them for their participation and to answer any study related questions. End of study 6 month visit. Participants will engage in a virtual visit for end of study procedures. At this follow-up visit, the Research Assistant will assess for any adverse events and direct the participant to collect a fasting blood sample for repeat LDL-C measurement. The Research Assistant will administer an electronic survey and knowledge questionnaires. Additional clinical visits as desired by the participants' physicians will be allowed at their discretion. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT05693701
Study type Interventional
Source University of Texas Southwestern Medical Center
Contact Amit Khera, MD
Phone 214.645.7500
Email Amit.Khera@UTSouthwestern.edu
Status Recruiting
Phase N/A
Start date February 27, 2023
Completion date February 28, 2027

See also
  Status Clinical Trial Phase
Completed NCT04067323 - Improvement of Nutritional Status and Blood Lipid Profile by Using MCT Oil on Overweight and Obese Women N/A
Completed NCT00651963 - Open Label Study Evaluating The Use Of Combination Therapy Of Ezetimibe And Statins In Patients With Dyslipidemia In Colombia (0653-141)(COMPLETED) Phase 4
Completed NCT01071278 - Lipid Management in Clinical Practice (MK-0524A-115) N/A
Completed NCT02603770 - Compare Pharmacokinetic(PK) Profiles of XZK vs Lovastatin in Healthy Male Volunteers Phase 1
Completed NCT05971017 - Health Effects of Biostimulated Lettuce in Human N/A
Completed NCT06061510 - Fish Oil-derived Omega-3 Fatty Acids on Gut Microbiota and Lipid Metabolome in Type 2 Diabetes Mellitus N/A
Active, not recruiting NCT05425745 - Evaluate the Effect of Obicetrapib in Patients With HeFH on Top of Maximum Tolerated Lipid-Modifying Therapies. Phase 3
Recruiting NCT05245357 - Impact of Foods on Bile Acids, Metabolites, and Inflammation N/A
Recruiting NCT06277713 - Preventing Exercise Resistance With Sedentary Interruptions N/A
Completed NCT03392701 - Possible Links Between Inflammation and Lipid Metabolism N/A
Completed NCT03236116 - Almond Consumption and Glycemia N/A
Completed NCT04088344 - Effect of a Carbohydrate-rich Diet in Healthy Subjects N/A